Armata Pharmaceuticals, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$36.6 | -$42.4 | -$40.9 | -$36.9 | -$23.8 |
| Net income | -$173.8 | -$18.9 | -$69.0 | -$36.9 | -$23.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$26.3 | -$39.4 | -$55.6 | -$34.7 | -$24.9 |
Shares outstanding 37.2M · Free float 99.4%
Annual filing data through FY ended December 31, 2025; float as of September 22, 2026.